CORAL GABLES, Fla., Jan. 31, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Steven R. Miller, Ph.D., Catalyst’s Chief Operating Officer and Chief Scientific Officer, will present CPP-115 progress at the 2012 Epilepsy Pipeline Update Conference on Thursday, February 2nd at 11:20 a.m. PST. The conference will be held on February 2nd through February 4th at the Hyatt Regency Hotel in San Francisco, California. Hosted by the Epilepsy Therapy Project, the 2012 Epilepsy Pipeline Update Conference is a showcase of emerging and established central nervous system (CNS) companies presenting their strategies, drug candidates and development programs to potential investors and partners.
